STOCK TITAN

Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference

Heartflow (Nasdaq: HTFL) said management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:30 p.m. PT / 3:30 p.m. ET.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Heartflow (Nasdaq: HTFL) said management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:30 p.m. PT / 3:30 p.m. ET. The session will be available live and archived on the company's Investor Relations website.

Investors can access the webcast and archived replay at https://ir.heartflow.com.

Loading...
Loading translation...
Argus Nov 20 session
+1.62% close to close 1.7x rel. volume Open Argus
Details

News Market Reaction – HTFL

On Nov 20, the first trading day after this news, HTFL closed 1.62% above the previous close. That session’s volume was 1.7x the stock’s average daily volume.

Data tracked by StockTitan Argus for the Nov 20 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Piper Sandler 37th Annual Healthcare Conference. The fireside chat will take place on Wednesday, December 3, 2025, at 12:30 p.m. PT / 3:30 p.m. ET.

A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at https://ir.heartflow.com.

About Heartflow’s Technology and Research
Heartflow’s technology is redefining precision cardiovascular care through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,400 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 600 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 500,000 patients worldwide. Key benefits include:

  • Proprietary data pipeline: Built from more than 110 million annotated CTA images, Heartflow’s data foundation powers advanced AI models that deliver highly accurate, reproducible insights across diverse patient populations.
  • Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 100 studies assessing over 365,000 patients. Proven in real-world practice with reproducibility and accuracy, Heartflow’s coronary CTA image acceptance rates exceed 96%.
  • Seamless clinical integration via upgraded workflow: Heartflow delivers final quality-reviewed analyses instantly upon order, enabling clinicians to move from diagnosis to decision without delay.
  • Quality system, global security and patient-data integrity compliance: Heartflow meets or exceeds leading international standards, including HITRUST, SOC 2 Type 2, ISO 13485, and ISO 27001.

About Heartflow, Inc.
Heartflow is transforming coronary artery disease from the world’s leading cause of death into a condition that can be detected early, diagnosed accurately, and managed for life. The Heartflow One platform uses AI to turn coronary CTA images into personalized 3D models of the heart, providing clinically meaningful, actionable insights into plaque location, volume, and composition and its effect on blood flow — all without invasive procedures. Discover how we’re shaping the future of cardiovascular care at heartflow.com.

Investor Contact
Nick Laudico
nlaudico@heartflow.com

Media Contact
Elliot Levy
elevy@heartflow.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Heartflow (HTFL) present at the Piper Sandler 37th Annual Healthcare Conference?

Heartflow will present on Wednesday, December 3, 2025 at 12:30 p.m. PT / 3:30 p.m. ET.

How can investors watch Heartflow's (HTFL) fireside chat on December 3, 2025?

The fireside chat will be available live and as an archived replay on the Heartflow Investor Relations site at https://ir.heartflow.com.

What topics will Heartflow (HTFL) management likely cover at the Piper Sandler conference?

The announcement states management will participate in a fireside chat; specific topics were not detailed in the notice.

Is the Heartflow (HTFL) webcast free and publicly accessible?

Yes; the company said the live webcast and archived version will be available on its Investor Relations website.

Will Heartflow (HTFL) provide a replay if I cannot attend the December 3, 2025 session live?

Yes; an archived version of the fireside chat will be posted on the Investor Relations website for later viewing.

Keep reading